Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0239946 (
liver fibrosis
)
8,268
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Ferroptosis is a recently discovered form of programmed cell death, but its regulatory mechanisms remain poorly understood. Here, we show that the RNA-binding protein ZFP36/TTP (ZFP36 ring finger protein) plays a crucial role in regulating ferroptosis in hepatic stellate cells (HSCs). Upon exposure to ferroptosis-inducing compounds, the ubiquitin ligase FBXW7/CDC4 (
F-box and WD repeat domain containing 7
) decreased ZFP36 protein expression by recognizing SFSGLPS motif.
FBXW7
plasmid contributed to classical ferroptotic events, whereas
ZFP36
plasmid impaired
FBXW7
plasmid-induced HSC ferroptosis. Interestingly,
ZFP36
plasmid inhibited macroautophagy/autophagy activation by destabilizing ATG16L1 (autophagy related 16 like 1) mRNA.
ATG16L1
plasmid eliminated the inhibitory action of
ZFP36
plasmid on ferroptosis, and
FBXW7
plasmid enhanced the effect of
ATG16L1
plasmid on autophagy. Importantly,
ZFP36
plasmid promoted
ATG16L1
mRNA decay via binding to the AU-rich elements (AREs) within the 3'-untranslated region. The internal mutation of the ARE region abrogated the ZFP36-mediated
ATG16L1
mRNA instability, and prevented
ZFP36
plasmid-mediated ferroptosis resistance. In mice, treatment with erastin and sorafenib alleviated murine
liver fibrosis
by inducing HSC ferroptosis. HSC-specific overexpression of
Zfp36
impaired erastin- or sorafenib-induced HSC ferroptosis. Noteworthy, we analyzed the effect of sorafenib on HSC ferroptosis in fibrotic patients with hepatocellular carcinoma receiving sorafenib monotherapy. Attractively, sorafenib monotherapy led to ZFP36 downregulation, ferritinophagy activation, and ferroptosis induction in human HSCs. Overall, these results revealed novel molecular mechanisms and signaling pathways of ferroptosis, and also identified ZFP36-autophagy-dependent ferroptosis as a potential target for the treatment of
liver fibrosis
.
...
PMID:RNA-binding protein ZFP36/TTP protects against ferroptosis by regulating autophagy signaling pathway in hepatic stellate cells. 3167 60